Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Capital Expenditures (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Capital Expenditures for 4 consecutive years, with $89000.0 as the latest value for Q4 2019.

  • On a quarterly basis, Capital Expenditures rose 106.75% to $89000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $162000.0, a 8.99% decrease, with the full-year FY2024 number at $37000.0, down 57.95% from a year prior.
  • Capital Expenditures was $89000.0 for Q4 2019 at Forte Biosciences, up from -$184000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $763000.0 in Q3 2018 to a low of -$1.3 million in Q4 2018.
  • A 4-year average of $61000.0 and a median of $123500.0 in 2016 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: tumbled 2360.0% in 2017, then soared 714.81% in 2018.
  • Forte Biosciences' Capital Expenditures stood at $10000.0 in 2016, then crashed by 2360.0% to -$226000.0 in 2017, then plummeted by 483.19% to -$1.3 million in 2018, then surged by 106.75% to $89000.0 in 2019.
  • Per Business Quant, the three most recent readings for FBRX's Capital Expenditures are $89000.0 (Q4 2019), -$184000.0 (Q3 2019), and $124000.0 (Q2 2019).